Table 2.
CD4+ and CD8+ T cell subsets responding to peptides 3 and 6.
In vitro proliferative responses (stimulation index)a |
|||||
---|---|---|---|---|---|
Immunizing Ag (200 μg/mouse) | Cell populations (2 × 105 cells) | Medium (cpm) | Peptide3 (100 μg/ml) | Peptide6 (100 μg/ml) | MOG35–55 (100 μg/ml) |
Peptide 3 | Unseparated | 2,387 | 18.0 ± 4.6 | 0.0 ± 0.5 | −1.0 ± 0.2 |
CD4+ | 1,911 | 24.0 ± 6.0 | 0.0 ± 0.3 | −1.0 ± 0.1 | |
CD8+ | 1,764 | −1.0 ± 0.0 | −0.1 ± 0.0 | −1.0 ± 0.3 | |
Peptide 6 | Unseparated | 2,005 | 0.0 ± 0.4 | 9.0 ± 0.8 | −1.0 ± 0.2 |
CD4+ | 1,793 | 0.0 ± 0.4 | 22.0 ± 3.2 | −1.0 ± 0.1 | |
CD8+ | 1,862 | 0.0 ± 1.9 | 0.0 ± 0.3 | 2.0 ± 0.5 |
Apoe−/− mice were immunized with P3 or P6 as described in Table 1. Ten days later, draining lymph node cells from both groups were isolated. The cells were passed through anti-CD4 microbead MAC columns and anti-CD8 columns from Miltenyi Biotech to positively isolate CD4+ and CD8+ T cells, respectively. Purified cells, together with unseparated cells were assayed for T cell proliferative responses. All cultures were established in triplicates, and the results were expressed as the mean number of counts per minute ± SEM.
aSIs are calculated by the following formula:
Bold font indicates the important data.